Moonlight Therapeutics, Inc.
Publicly observedMarietta, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Marietta | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Moonlight Therapeutics, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | S6TTK8Y6R5A1 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant2 Jun 2025Publicly observed
NIH SBIR/STTR award: Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy
USD 999,927.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant2 Jun 2025Publicly observed
NIH SBIR/STTR award: Safety and Tolerability of TASIS-Peanut (Targeted Allergen Specific Immunotherapy within the Skin) patch for the Treatment of Peanut Allergy
USD 999,658.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant6 May 2024Publicly observed
NIH SBIR/STTR award: Scale-up manufacturing of microneedle stamp for peanut allergen immunotherapy
USD 999,380.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant6 May 2024Publicly observed
NIH SBIR/STTR award: Scale-up manufacturing of microneedle stamp for peanut allergen immunotherapy
USD 997,668.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.